|
KMID : 0358219940210010043
|
|
Korean Journal of Fertility and Sterility
1994 Volume.21 No. 1 p.43 ~ p.48
|
|
|
Treatment of Uterine Myoma as a Cause of infertility, with a Delayed-Release Formulation of a Gonadotropin-Releasing Hormone Agonist (D-Trp6-LHRH)
|
|
박세출
권경익/남동호/이민용/임춘근/양숙경/최종무/이두룡
|
|
|
Abstract
|
|
|
To evaluate the effectiveness of GnRH agonist for the treatment of uterine myoma as a cause of infertility, fourteen women were recruited to the study. The patients were treated with a delayed-release formulation of D-Trp6-LHRH in biodegradable
microcapsules (Decapeptyl-CR), administered intramuscularly at four week intervals for a period of six monthes.
The first injection was given on day 21 of the cycle. Serum estradiol levels fell significantly to the mean value of 257.7pg/ml 4 weeks after the first injection.
Eleven patients in fourteen treated patients had a reduction in the size of uterine myoma as assessed by ultrasonography, two patients had no change of size and one patient had a increase of size.
After the first or second injection, all patients became amenorrheic, then resumption of menstruation ocurred at 12 to 14 weeks after the last injection.
Common side effects were hot flush, sweating and dyspareunia, whitch were acceptable.
In Eleven patients who had a reduction in the size of uterine myoma by treatment with a delayed-release formulation of D-Trp6-LHRH (Decapeptyl-CR), after above treatment with GnRH agonist, then four patients were treated with myomectomy, three
patients
had pregnancy and full term delivered by Cesarean section.
These data suggest that administration of a delayed-release formulation of a GnRH agonist can be a worthwhile and convenient approach to the medical treatment of uterine myoma as a cause of infertility.
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|